AngioDynamics, Inc. (ANGO)

Market Cap	231.52M
Revenue (ttm)	324.01M
Net Income (ttm)	-192.37M
Shares Out	40.05M
EPS (ttm)	-4.78
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	360,627
Open	5.80
Previous Close	5.87
Day's Range	5.72 - 5.85
52-Week Range	5.26 - 11.38
Beta	0.68
Analysts	Strong Buy
Price Target	14.25 (+146.54%)
Earnings Date	Apr 4, 2024

About ANGO

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that elim...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 27, 2004
• Employees: 815
• Stock Exchange: NASDAQ
• Ticker Symbol: ANGO

Financial Performance

In 2023, AngioDynamics's revenue was $338.75 million, an increase of 7.13% compared to the previous year's $316.22 million. Losses were -$52.44 million, 97.5% more than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for ANGO stock is "Strong Buy." The 12-month stock price forecast is $14.25, which is an increase of 146.54% from the latest price.

Price Target

$14.25

(146.54% upside)

Analyst Consensus: Strong Buy